RESEARCH PAPER
Patients’ experiences of treatment migration from ART triple pill to fixed-dose combination therapy in Ngaka Modiri Molema District, North West Province, South Africa
1
Ditsobotla District, Department of Health, North West Province, South Africa
2
Department of Psychology, Faculty of Health Sciences, University of Venda, South Africa
3
Department of Advanced Nursing Sciences, Faculty of Health Sciences, University of Venda, South Africa
4
Office of the Executive Dean, Faculty of Health Sciences, University of Venda, South Africa
Submission date: 2021-05-22
Final revision date: 2021-07-12
Acceptance date: 2021-07-19
Publication date: 2023-03-29
HIV & AIDS Review 2023;22(2):150-159
KEYWORDS
antiretroviral therapyexperiencesfixed-dose combinationpeople living with human immu- nodeficiency virustriple pill
TOPICS
ABSTRACT
Introduction:
Migration of people living with human immunodeficiency virus (PLWH) from triple pill therapy to a fixed-dose combination (FDC) was initiated to the public sector of South Africa to help with adherence to treatment as it would reduce the pill burden significantly. PLWH experiences regard- ing the transition from triple pill therapy to FDC in antiretroviral therapy (ART) remain unknown.
Material and methods:
This study explores and describes the experiences of PLWH regarding migra- tion from triple pill therapy to FDC. The study was conducted in Community Health Centres (CHC) in Ngaka Modiri Molema District in the North West province, South Africa. A qualitative exploratory descriptive design was used and the target population comprised all PLWH who have been on ART for more than a year on the triple pill and are currently on FDC. A purposive sampling technique was used and the sample size was determined by data saturation (n = 15). Data collection was done using unstructured interviews, using audiotapes and field notes. Data analysis was done using ATLAS.ti and followed the notice-collect-think (NCT) analysis.
Results:
Results were discussed based on three themes: challenges experienced through the triple pill, factors influencing intake of FDC and other factors that negatively influence the triple pill and FDC intake.
Conclusions:
These findings provide insight into why patients do not adhere to ART. A focus on treat- ment education would promote knowledge among patients, increase responsibility, and enhance adher- ence. Support groups and treatment buddies must be emphasized in the provision of support for clients, even if community health workers can be involved.
Migration of people living with human immunodeficiency virus (PLWH) from triple pill therapy to a fixed-dose combination (FDC) was initiated to the public sector of South Africa to help with adherence to treatment as it would reduce the pill burden significantly. PLWH experiences regard- ing the transition from triple pill therapy to FDC in antiretroviral therapy (ART) remain unknown.
Material and methods:
This study explores and describes the experiences of PLWH regarding migra- tion from triple pill therapy to FDC. The study was conducted in Community Health Centres (CHC) in Ngaka Modiri Molema District in the North West province, South Africa. A qualitative exploratory descriptive design was used and the target population comprised all PLWH who have been on ART for more than a year on the triple pill and are currently on FDC. A purposive sampling technique was used and the sample size was determined by data saturation (n = 15). Data collection was done using unstructured interviews, using audiotapes and field notes. Data analysis was done using ATLAS.ti and followed the notice-collect-think (NCT) analysis.
Results:
Results were discussed based on three themes: challenges experienced through the triple pill, factors influencing intake of FDC and other factors that negatively influence the triple pill and FDC intake.
Conclusions:
These findings provide insight into why patients do not adhere to ART. A focus on treat- ment education would promote knowledge among patients, increase responsibility, and enhance adher- ence. Support groups and treatment buddies must be emphasized in the provision of support for clients, even if community health workers can be involved.
REFERENCES (47)
1.
Beck EJ, Mandalia S, Sangha R, et al. Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008. PLoS One 2012; 7: e47376.
2.
Schaecher KL. The importance of treatment adherence in HIV. Am J Manag Care 2013; 19 (12 Suppl): S231-S237.
3.
Ojieabu WA. Pharmacist’s intervention on pill burden effects on the health-related quality of life of elderly diabetic patients in a tertiary hospital in Southwestern Nigeria. Int J Diabetes Metab 2019; 25: 148-154.
5.
World Health Organization. Global Health Observatory (GHO) data. 2020. https://www.who.int/health-top....
6.
Statistics South Africa [StatsSA]. Mid-year population estimates 2020, statistical release. Pretoria. 2020. p0302.
7.
Li L, Wu Z, Wu S, Jia M, Lieber E, Lu Y. Impacts of HIV/AIDS stigma on family identity and interactions in china. Families, Systems & Health 2008; 26: 431.
8.
Zeng C, Li X, Qiao S, Yang X, Shen Z, Zhou Y. Anticipated stigma and medication adherence among people living with HIV: the mechanistic roles of medication support and ART self-efficacy. AIDS Care 2020; 32: 1014-1022.
9.
Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M. “If I have nothing to eat, I get angry and push the pills bottle away from me”: a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care 2013; 25: 1271-1277.
10.
Brinkley-Rubinstein L, Chadwick C, Graci M. The connection between serious life events, anti-retroviral adherence, and mental health among HIV-positive individuals in the Western Cape, South Africa. AIDS Care 2013; 25: 1581-1585.
11.
Penn C, Watermeyer J, Evans M. Why don’t patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS. Patient Educ Couns 2011; 83: 310-318.
12.
Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy 2006; 26: 1111-1133.
13.
Safira N, Lubis R, Fahdhy M. Factors affecting adherence to antiretroviral therapy. KnE Life Sciences 2018; 4: 60-70. doi: https://doi.org/10.18502/kls.v....
14.
Boruett P, Kagai D, Njogo S, et al. Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya – a quasi-experimental study using time series analysis. BMC Health Serv Res 2013; 13: 242. doi: 10.1186/1472-6963-13-242.
15.
Marazzi MC, Bartolo M, Gialloreti LE, et al. Improving adherence to highly active anti-retroviral therapy in Africa: the DREAM programme in Mozambique. Health Educ Res 2006; 21: 34-42.
16.
Gandhi M, Gandhi RT. Single-pill combination regimens for treatment of HIV-1 infection. N Engl J Med 2014; 371: 248-259.
17.
Davies NE. Fixed-dose combination for adults accessing antiretroviral therapy: advice document. Southern African Journal of HIV Medicine 2013; 14: 41-43.
18.
Sax PE, Meyers JL, Mugavero M, Davis KL. Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. PLoS One 2012; 7: e31591. doi: 10.1371/journal.pone.0031591.
19.
Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care 2007; 19: 28-33.
20.
Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health 2007; 97: 2238-2245.
21.
Li MJ, Murray JK, Suwanteerangkul J, Wiwatanadate P. Stigma, social support, and treatment adherence among HIV-positive patients in Chiang Mai, Thailand. AIDS Educ Prev 2014; 26: 471-483.
22.
Enriquez M, McKinsey DS. Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level. HIV/AIDS (Auckl) 2011; 3: 45-51.
23.
Wagner GJ, Linnemayr S, Ghosh-Dastidar B, Currier JS, Hoffman R, Schneider S. Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial. Trials 2016; 17: 162. doi: 10.1186/s13063-016-1287-3.
24.
Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296: 679-690.
25.
Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 2006; 20: 1163-1169.
26.
Duse AG, Morar A, Landman I, et al. Short-term effectiveness and safety of HAART in the form of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (Triviro) in HIV-1-infected adults in Zimbabwe. Southern African Journal of HIV Medicine 2008; 9: 51-56.
27.
Creswell JW, Creswell JD. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. Sage Publications; 2017.
28.
Brink H, Van der Walt C, Van Rensburg G. Fundamentals of Research Methodology for Health Care Professionals. Cape Town: Juta and Company Ltd; 2012.
29.
Grove SK, Gray JR. Understanding Nursing Research E-Book: Building an Evidence-Based Practice. Elsevier Health Sciences; 2018.
30.
Osler M, Hilderbrand K, Hennessey C, et al. A three‐tier framework for monitoring antiretroviral therapy in high HIV burden settings. J Int AIDS Soc 2014; 17: 18908. doi: 10.7448/IAS.17.1.18908.
32.
Meno FO, Makhado L, Matsipane M. Factors inhibiting implementation of integrated management of childhood illnesses (IMCI) in primary health care (PHC) facilities in Mafikeng sub-district. International Journal of Africa Nursing Sciences 2019; 11: 100161. doi: https://doi.org/10.1016/j.ijan....
33.
Makhado L, Davhana-Maselesele M, Lebese RT, Maputle SM. Factors facilitating trained NIMART nurses’ adherence to treatment guidelines: a vital matter in the management of TB/HIV treatment in South Africa. BMC Nurs 2020; 19: 77. doi: 10.1186/s12912-020-00470-6.
34.
Morrow SL. Quality and trustworthiness in qualitative research in counseling psychology. J Couns Psychol 2005; 52: 250-260.
35.
Hornschuh S, Dietrich JJ, Tshabalala C, Laher F. Antiretroviral treatment adherence: knowledge and experiences among adolescents and young adults in Soweto, South Africa. AIDS Res Treat 2017; 2017: 5192516. doi: 10.1155/2017/5192516.
36.
Mwangome M, Geubbels E, Klatser P, Dieleman M. Perceptions on diabetes care provision among health providers in rural Tanzania: a qualitative study. Health Policy Plan 2017; 32: 418-429.
37.
Lazuardi E, Newman CE, Anintya I, et al. Increasing HIV treatment access, uptake and use among men who have sex with men in urban Indonesia: evidence from a qualitative study in three cities. Health Policy Plan 2020; 35: 16-25.
38.
Bogart LM, Mosepele M, Phaladze N, et al. A social network analysis of HIV treatment partners and patient viral suppression in Botswana. J Acquir Immune Defic Syndr 2018; 78: 183-192.
39.
Rivera-Díaz M, Varas-Díaz N, Padilla M, de los Angeles Vargas-Cancel M, Serrano N. Family interaction and social stigmatization of people living with HIV and AIDS in Puerto Rico. Glob Soc Work 2017; 7: 3-26.
40.
Ibrahim K, Kombong R, Sriati A. The difference of perceived HIV stigma between people living with HIV infection and their families. Nurse Media Journal of Nursing 2019; 9: 117-127.
41.
Woodgate RL, Zurba M, Tennent P, Cochrane C, Payne M, Mignone J. “People try and label me as someone I’m not”: the social ecology of Indigenous people living with HIV, stigma, and discrimination in Manitoba, Canada. Soc Sci Med 2017; 194: 17-24.
42.
Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM. Framing mechanisms linking HIV-related stigma, adherence to treatment, and health outcomes. Am J Public Health 2017; 107: 863-869.
43.
Ismail SM, Eisa AA, Ibrahim F. HIV-infected people in Sudan moving toward chronic poverty: possible interventions. J Assoc Nurses AIDS Care 2016; 27: 30-43.
44.
Idemudia ES, Olasupo MO, Modibo MW. Stigma and chronic illness: a comparative study of people living with HIV and/or AIDS and people living with hypertension in Limpopo Province, South Africa. Curationis 2018; 41: e1-e5. doi: 10.4102/curationis.v41i1.1879.
45.
Azia IN, Mukumbang FC, van Wyk B. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. South Afr J HIV Med 2016; 17: 476. doi: 10.4102/sajhivmed.v17i1.476.
46.
Chop E, Duggaraju A, Malley A, et al. Food insecurity, sexual risk behavior, and adherence to antiretroviral therapy among women living with HIV: a systematic review. Health Care Women Int 2017; 38: 927-944.
47.
Ntshakala TT, Mavundla TR, Dolamo BL. Quality of life domains relevant to people living with HIV and AIDS who are on antiretroviral therapy in Swaziland. Curationis 2012; 35: 87. doi: 10.4102/curationis.v35i1.87.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
